In 2022, the Association for Regenerative Medicine (ARM) reported that over 2,000 clinical trials employed cell therapy, cell-based immuno-oncology, gene therapy, or tissue engineering. The cells ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback